Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI)
San Francisco VA Medical Center · University of California, San Francisco · +9 more institutions
Abstract
With the increasing life expectancy in developed countries, the incidence of Alzheimer's disease (AD) and thus its socioeconomic impact are growing. Increasing knowledge over the last years about the pathomechanisms involved in AD allow for the development of specific treatment strategies aimed at slowing down or even preventing neuronal death in AD. However, this requires also that (1) AD can be diagnosed with high accuracy, because non-AD dementias would not benefit from an AD-specific treatment; (2) AD can be diagnosed in very early stages when any intervention would be most effective; and (3) treatment efficacy can be reliably and meaningfully monitored. Although there currently is no ideal biomarker that…
Citation impact
- FWCI
- 5.90
- Percentile
- 100%
- References
- 126
Authors
9- SGSusanne G. Mueller
San Francisco VA Medical Center, University of California, San Francisco
- MWMichael W. WeinerCorresponding
San Francisco VA Medical Center, University of California, San Francisco
- LJLeon J. Thal
University of San Diego, University of California San Diego
- RCRonald C. Petersen
Mayo Clinic
- CRClifford R. Jack
Mayo Clinic
Topics & keywords
- Neuroimaging
- Disease
- Biomarker
- Medicine
- Alzheimer's Disease Neuroimaging Initiative
- Alzheimer's disease
- Life expectancy
- Neuroscience
- Partnerships for the goals